BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Alligator Bioscience - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Alligator Bioscience
X-ORIGINAL-URL:https://alligatorbioscience.se
X-WR-CALDESC:Events for Alligator Bioscience
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231114
DTEND;VALUE=DATE:20231117
DTSTAMP:20260425T183233
CREATED:20231109T084821Z
LAST-MODIFIED:20231109T084821Z
UID:8988-1699920000-1700179199@alligatorbioscience.se
SUMMARY:Jefferies London Healthcare Conference
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/jefferies-london-healthcare-conference/
LOCATION:Waldorf Hilton (Aldwych)\, Aldwych\, London\, WC2B 4DD\, Storbritannien (Förenade kungariket Storbritannien)
CATEGORIES:Investor events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231114
DTEND;VALUE=DATE:20231117
DTSTAMP:20260425T183233
CREATED:20231109T085157Z
LAST-MODIFIED:20231109T085157Z
UID:9001-1699920000-1700179199@alligatorbioscience.se
SUMMARY:15th Annual PEGS Europe - Protein & Antibody Engineering Summit
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/15th-annual-pegs-europe-protein-antibody-engineering-summit/
LOCATION:Lisbon Congress Center\, Praça das Indústrias 1\, Lisbon\, 1300-307\, Portugal
CATEGORIES:Scientific meetings
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20231122T161500
DTEND;TZID=Europe/Stockholm:20231122T163000
DTSTAMP:20260425T183233
CREATED:20231109T084951Z
LAST-MODIFIED:20231109T084951Z
UID:8995-1700669700-1700670600@alligatorbioscience.se
SUMMARY:ØU Life Science Investor Konference
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/ou-life-science-investor-konference/
LOCATION:Copenhagen\, Copenhagen\, Danmark
CATEGORIES:Investor events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20231201T140000
DTEND;TZID=Europe/Stockholm:20231201T160000
DTSTAMP:20260425T183233
CREATED:20231122T110142Z
LAST-MODIFIED:20231122T110229Z
UID:9028-1701439200-1701446400@alligatorbioscience.se
SUMMARY:Capital Markets Day 2023
DESCRIPTION:Lund\, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces it will hold a Capital Markets Day on December 1\, 2023. The event will be hosted by members of Alligator’s executive management team who will provide an overview of the Company’s strategy\, its prorietary and partnered assets\, and its technology platforms. \nCapital Markets Day Details \n\nDate/Time: Friday\, December 1\, 2023 at 2:00 PM CET / 8:00 AM EST\nLocation: 7A Posthuset\, Vasagatan 28\, Stockholm\, Sweden\nFormat: In-person event to be streamed live\n\nTo attend the event in person\, contact IR & Communications Manager\, Greta Eklund\, at ir@alligatorbioscience.com. Please note that the number of seats is limited. \nThe event will be live-streamed to Alligator’s Youtube channel\, accessible through this link. \nCapital Markets Day Agenda \n\nOverview of Alligator Bioscience: Chief Executive Officer Søren Bregenholt will present an overview of the Company’s strategic direction and its prorietary and partnered assets\nLead Asset Mitazalimab: Chief Medical Officer Dr. Sumeet Ambarkhane will provide an update on the clinical data generated so far by mitazalimab along with a broader view of the Company’s CD40 program\nKey Opinon Leader: Dr. Gregory Beatty\, Associate Professor of Medicine at the University of Pennsylvania\, will explain the current treatment landscape for pancreatic cancer and the potential of mitazalimab to change the treatment paradigm\nAlligator’s Technology Platforms: Chief Technology Officer Laura von Schantz will discuss Alligator’s proprietary technology platforms Neo-X-Prime™ and Ruby™\, including the pivotal role Ruby™ is playing in Alligator’s research collaboration and license agreement with Orion Corporation\nATOR-4066: Chief Scientific Officer Peter Ellmark will look at the progress Alligator is making with ATOR-4066\, a third generation bispecific antibody targeting CD40 and CEACAM5\, developed by the Company’s Neo-X-Prime™ platform\n4-1BB: Chief Medical Officer Dr. Sumeet Ambarkhane will provide the latest updates on ATOR-1017\, Alligator’s 4-1BB monoclonal antibody with best-in-class potential\, and ALG.APV-527\, a bispecific antibody with a tumor-directed 4-1BB agonistic effect being co-developed with Aptevo Therapeutics\n\nLive question and answer sessions will be held after each presentation and CEO Søren Bregenholt will provide concluding remarks and present Alligator’s strategic outlook at the end of the event.
URL:https://alligatorbioscience.se/en/event/kapitalmarknadsdag-1-december/
LOCATION:7A Posthuset\, Vasagatan 28\, Stockholm\, Sverige
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240208
DTEND;VALUE=DATE:20240209
DTSTAMP:20260425T183233
CREATED:20231109T090505Z
LAST-MODIFIED:20231109T090505Z
UID:9009-1707350400-1707436799@alligatorbioscience.se
SUMMARY:Year-end report 2023
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/year-end-report-2023/
CATEGORIES:Financial events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240301
DTEND;VALUE=DATE:20240401
DTSTAMP:20260425T183233
CREATED:20231109T090720Z
LAST-MODIFIED:20231109T090720Z
UID:9013-1709251200-1711929599@alligatorbioscience.se
SUMMARY:Annual Report 2023
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/annual-report-2023/
CATEGORIES:Financial events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240506
DTEND;VALUE=DATE:20240507
DTSTAMP:20260425T183233
CREATED:20231109T090924Z
LAST-MODIFIED:20240209T131922Z
UID:9017-1714953600-1715039999@alligatorbioscience.se
SUMMARY:Interim report January - March 2024
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/interim-report-january-march-2024/
CATEGORIES:Financial events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240507
DTEND;VALUE=DATE:20240508
DTSTAMP:20260425T183233
CREATED:20231109T091203Z
LAST-MODIFIED:20231109T091203Z
UID:9021-1715040000-1715126399@alligatorbioscience.se
SUMMARY:Annual General Meeting 2024
DESCRIPTION:
URL:https://alligatorbioscience.se/en/event/annual-general-meeting-2024/
LOCATION:Lund\, Lund\, S-22381\, Sverige
CATEGORIES:Annual General Meeting,Financial events
END:VEVENT
END:VCALENDAR